Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relationships, sexuality and sexual activity, and mental health.  The trial will evaluate how well investigational medications work within the body and/or how safe it is compared to placebo (does not contain treatment drug). The trial will assess the dysmenorrhea (painful periods) response in participants with endometriosis and associated pain. To learn more about this study, call us at 843-851-7098.

Uterine Fibroids are muscular tumors that grow in the wall of the uterus (womb). Fibroids are almost always benign (not cancerous).  Some signs and symptoms of uterine fibroids include heavy bleeding, pain, and constipation. If you feel you might have uterine fibroids and would like to learn more about a trial with an investigational medication, please call us at 843-851-7098.

Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat builds up in your liver. This buildup of fat is not caused by heavy alcohol use.  NAFLD is one of the most common causes of liver disease in the United States.  This build up can potentially lead to fibrosis, cirrhosis, or liver disease.  Palmetto Clinical Research is conducting a trial that involves an investigational medication for the potential treatment of NAFLD.  If interested, please call us at 843-851-7098.  

NASH is the form of NAFLD in which you have inflammation of the liver and liver damage, in addition to fat in your liver. The inflammation and liver damage of NASH can cause fibrosis, or scarring, of the liver. NASH may lead to cirrhosis, in which the liver is scarred and permanently damaged. Cirrhosis can lead to liver cancer .  (https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts)

Palmetto Clinical Research is conducting a trial that involves an investigational medication for the potential treatment of NASH.  If interested, please call us at 843-851-7098.  

Alzheimer’s disease is the most common type of dementia.  It is a progressive disease beginning with mild memory loss and possibly leading to loss of the ability to carry on a conversation and respond to the environment.  Alzheimer’s disease involves parts of the brain that control thought, memory, and language.  In 2020 as many as 5.8 million Americans were living with Alzheimer’s disease.  Some warning signs can be memory loss that disrupts daily life, trouble handling money and paying bills, or decreased judgement. (https://www.cdc.gov/aging/aginginfo/alzheimers.htm)

Palmetto Clinical Research is conducting several trials that involve an investigational medications for the potential treatment of Alzheimer’s disease.  Each trial involves Alzheimer’s at different stages.  If interested, please call us at 843-851-7098.